Clinical Trial Update: A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for RT001 evaluating efficacy and safety in Infantile Neuroaxonal Dystrophy across Phase 2 and Phase 3; status: active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Neuroaxonal Dystrophy

Drugs mentioned

• RT001

Snippet

Sponsor: Biojiva LLC | Conditions: Infantile Neuroaxonal Dystrophy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING